Cook Medical’s Evolution® RL Lead Extraction Products reintroduced to the US market

Effective immediately, Cook Medical customers in the United States will again have access to its Evolution® RL and Evolution® Shortie RL Controlled-Rotation Dilator Sheath Sets. Distribution of these products within the U.S. market was suspended for two months while Cook’s Lead Management clinical division worked with the U.S. Food and Drug Administration (FDA) to resolve agency questions about the marketing clearance of these products. The devices, which remained available in Europe and other markets, were not recalled by FDA.

“For a quarter century, Cook has been at the forefront of cardiac lead extraction technology. Our latest devices in the Evolution RL line offer physicians the ability to control either uni-directional or bi-directional operation for mechanical extraction of problematic pacemaker and ICD leads and indwelling catheters,” said Louis Goode, vice president and global leader of Cook Medical’s Lead Extraction division. “We’re very pleased to be able to again provide these devices to U.S. physicians.”

Both the Evolution RL and Evolution Shortie RL, he added, are indicated for use in cardiac rhythm management patients requiring the percutaneous dilation of tissue surrounding cardiac leads, indwelling catheters and foreign objects. See Instructions For Use.

Earlier this year, the Lead Management division launched an educational website on Cook’s role in supporting the development of the mechanical lead extraction procedure and the devices needed to perform these operations. For more information, visit https://www.cookmedical.com/

About Cook Medical

Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world's healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at www.cookmedical.com, and for the latest news, follow us on Twitter, Facebook and LinkedIn.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    COOK MEDICAL INC.. (2023, April 08). Cook Medical’s Evolution® RL Lead Extraction Products reintroduced to the US market. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20140710/Cook-Medicals-Evolution-RL-Lead-Extraction-Products-reintroduced-to-the-US-market.aspx.

  • MLA

    COOK MEDICAL INC.. "Cook Medical’s Evolution® RL Lead Extraction Products reintroduced to the US market". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20140710/Cook-Medicals-Evolution-RL-Lead-Extraction-Products-reintroduced-to-the-US-market.aspx>.

  • Chicago

    COOK MEDICAL INC.. "Cook Medical’s Evolution® RL Lead Extraction Products reintroduced to the US market". News-Medical. https://www.news-medical.net/news/20140710/Cook-Medicals-Evolution-RL-Lead-Extraction-Products-reintroduced-to-the-US-market.aspx. (accessed December 22, 2024).

  • Harvard

    COOK MEDICAL INC.. 2023. Cook Medical’s Evolution® RL Lead Extraction Products reintroduced to the US market. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20140710/Cook-Medicals-Evolution-RL-Lead-Extraction-Products-reintroduced-to-the-US-market.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Clinical trial results of drug-eluting stent for peripheral arterial disease presented at LINC 2015